$KVUE ... Kimberly-Clark KMB.N said on Monday it will acquire Tylenol maker Kenvue KVUE.N in a deal valued at about $48.7 billion, creating a consumer goods giant.
Kenvue's shares were up 18% in premarket trading. Kimberly-Clark said it would buy all of the outstanding shares of Kenvue common stock in a cash-and-stock transaction.
Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.
That implies a per-share deal value of $21.01, or an equity value of $40.32 billion, according to Reuters calculations.
@JonahLupton@TrendSpider Austin on par with Phoenix .. Jan hit or miss on weather but we got live music bbq distilleries .. lots of fun things to do. Let me know if you want more details or help planning it. Can get a hotel block too as we have hoteliers with properties here.
@saxena_puru@GVStumpo I can see why people bash you puru! You got to keep it real and not be wishy washy. Why not tell this story on Monday when you got out of the stock and not today. It is not a good look.
Get in touch if you would like me to manage your unused travel credits. Each airline has a different policy that are being updated all the time, let me stay on top of this for you so you don't miss out 💸 #futuretravel#personaltravelassistant#digitaltravelcompanion
@chamath@LondonBreed@FrancisSuarez It’s out of control. The state needs a cleansing and return to its former glory. This means an exodus and policy reform at the state level.